Hypofractionated PBI After BCS for Low-risk Breast Cancer Patients

NCT03411174 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 220

Last updated 2025-05-13

No results posted yet for this study

Summary

The study was designed to evaluate the feasibility and safety of hypofractionated partial breast irradiation after breast-conserving surgery for low-risk breast cancer patients.

Conditions

Interventions

RADIATION

hypofractionated partial breast irradiation

deliver 40Gy/15Fx to tumor bed areas

Sponsors & Collaborators

  • Fudan University

    lead OTHER

Principal Investigators

  • Jinli Ma, MD,PhD · Fudan University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Max Age
85 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2019-07-15
Completion
2019-07-15

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03411174 on ClinicalTrials.gov